This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Company News for May 21, 2020
by Zacks Equity Research
Companies In The News Are: MRNA, FB, CLX, RCL.
Clorox (CLX) Announces a Dividend Hike, Cheers Investors
by Zacks Equity Research
Clorox (CLX) gives investors another reason to cheer by raising its dividend for the 51st consecutive quarter. Its IGNITE strategy and strong demand place it well for further growth.
Top Stock Picks for Week of May 18, 2020
by Panel Of Zacks Experts
Consumer Products & Chips in Focus.
Is Clorox (CLX) Stock Still a Great Buy for the Eventual Coronavirus Recovery?
by Benjamin Rains
Clorox topped our quarterly earnings and revenue estimates on May 1, and the stock has jumped 12% since the end of April. Some investors might think the rally is overdone. But is Clorox still a great buy even near its new highs?
The Zacks Analyst Blog Highlights: NVIDIA, Moderna, Clorox, Campbell Soup and General Mills
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NVIDIA, Moderna, Clorox, Campbell Soup and General Mills
Zacks.com featured highlights include: BWX, Clorox, Microsoft and Jack Henry
by Zacks Equity Research
Zacks.com featured highlights include: BWX, Clorox, Microsoft and Jack Henry
Zacks.com featured highlights include: Clorox, Sprouts Farmers, Eli Lilly, Gold Fields and AngloGold
by Zacks Equity Research
Zacks.com featured highlights include: Clorox, Sprouts Farmers, Eli Lilly, Gold Fields and AngloGold
4 GARP Stocks to Scoop Up for Maximum Returns
by Zacks Equity Research
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
Fight Off the Coronavirus Blues With 5 Low-Beta Stocks
by Nilanjan Banerjee
It is an ideal time to invest in low-beta stocks since they might provide a shield against coronavirus-induced market volatility.
Rebalance Your Portfolio to Counter Dilemma Over Recovery
by Nalak Das
At this stage, a combination of aggressive and defensive stocks after filtering with proper selection criteria will be prudent for one's portfolio.
3 Reasons Why Clorox (CLX) Is a Great Growth Stock
by Zacks Equity Research
Clorox (CLX) could produce exceptional returns because of its solid growth attributes.
The Zacks Analyst Blog Highlights: Wayfair, Chegg, Moderna, Quidel and Clorox
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Wayfair, Chegg, Moderna, Quidel and Clorox
International Flavors (IFF) Beats on Q1 Earnings, Scraps View
by Zacks Equity Research
International Flavors (IFF) registers sales and earnings growth in Q1 on broad-based growth in Scent and Taste segments.
PepsiCo Expands Digital Footprint to Meet Consumers' Needs
by Zacks Equity Research
PepsiCo (PEP) launches two websites to cater to the growing online demand for food and beverages.
Is The Clorox (CLX) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (CLX) Outperforming Other Consumer Staples Stocks This Year?
An Outstanding Week for Market Amid Record Job Losses: 5 Picks
by Nalak Das
Market's worst is behind us as negative estimates are already factored in valuations.
Zacks.com featured highlights include: Logitech International, MACOM Technology Solutions, Murphy USA, Vertex Pharmaceuticals and The Clorox Company
by Zacks Equity Research
Zacks.com featured highlights include: Logitech International, MACOM Technology Solutions, Murphy USA, Vertex Pharmaceuticals and The Clorox Company
Hain Celestial (HAIN) Up on Q3 Earnings Beat & Raised View
by Zacks Equity Research
Smooth execution of the transformation plan aided Hain Celestial's (HAIN) third-quarter fiscal 2020 performance.
AB InBev (BUD) Posts Q1 Loss on Declines in On-Premise Volume
by Zacks Equity Research
AB InBev's (BUD) first-quarter 2020 results reflect a decline in volume due to the closure of the on-premise channel in most markets, owing to the coronavirus pandemic.
5 Stocks That Look Appealing on Relative Price Strength
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
Top Ranked Momentum Stocks to Buy for May 7th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 7th.
Will Clorox (CLX) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Clorox (CLX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Company News for May 4, 2020
by Zacks Equity Research
Companies in the news are: CLX, CCJ, QSR, BERY
Earnings Data Deluge
by Zacks Equity Research
Earnings Data Deluge.
Clorox (CLX) Q3 Earnings Top, View Up on Coronavirus-Led Demand
by Zacks Equity Research
Strong growth in the disinfecting products and unique product portfolio aided Clorox's (CLX) third-quarter fiscal 2020 results.